BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan SK, Du P, Ignacio C, Mehta S, Newton IG, Steinmetz NF. Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays. Biomacromolecules 2021;22:1231-43. [PMID: 33539086 DOI: 10.1021/acs.biomac.0c01727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Vindeirinho JM, Pinho E, Azevedo NF, Almeida C. SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond. Front Cell Infect Microbiol 2022;12:799678. [DOI: 10.3389/fcimb.2022.799678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Abolmaali SS, Alimardani V, Farahavar G, Najafi H, Shafiee M, Tanideh N, Tamaddon AM, Ahadian S. Nanotechnology-based approaches against COVID-19. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00012-9] [Reference Citation Analysis]
3 Varlamova EG, Turovsky EA, Blinova EV. Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles. Int J Mol Sci 2021;22:10808. [PMID: 34639150 DOI: 10.3390/ijms221910808] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
4 Etienne EE, Nunna BB, Talukder N, Wang Y, Lee ES. COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis. Bioengineering (Basel) 2021;8:98. [PMID: 34356205 DOI: 10.3390/bioengineering8070098] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]